39 /100
MEDIUM RISK
Score updated May 30, 2026

CADL — Candel Therapeutics, Inc. Dilution Risk Tracker

Track CADL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CADL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
25%
📉 Score Deterioration 40%
• Score rose 19 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $100M remaining capacity
🔔 Track CADL — Get forecast alerts →

💹 Market Data

Market Cap$608.14M
Shares Outstanding73.27M
Float56.91M
Cash$194.83M
Debt$49.27M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.8% shares (2025Q4 vs prior)
84 institutional holders · 24.13M shares
#1 FMR LLC 8.23M shares
#2 BlackRock, Inc. 2.86M shares
#3 ACORN CAPITAL ADVISORS, LLC 2.58M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.42M
Days to Cover5.5
% of Float25.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Feb 26, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CADL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CADL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CADL
📊 CADL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CADL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.